CSF3 and neoplasm: Human MDSCs induced by granulocyte colony-stimulating factor (G-CSF) and granulocyte macrophage colony-stimulating factor (GM-CSF) inhibit T cell immunity in the tumor microenvironment in patients with cancer [135].